Efficacy Study of Acupuncture to Treat the Upper Abdominal Pain of Cancer Patients
Pilot Study of Acupuncture to Alleviate the Upper Abdominal Pain of Cancer Patients Treated With Neurolytic Celiac Plexus Block
1 other identifier
interventional
14
1 country
1
Brief Summary
This study is to investigate the effectiveness of acupuncture for alleviating the upper abdominal pain of cancer patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 29, 2013
CompletedFirst Posted
Study publicly available on registry
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedDecember 22, 2021
December 1, 2021
1 year
July 29, 2013
December 7, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Visual analogue scale(VAS)
The patients will be required to document 100mm pain VAS, where '0' represents 'no pain' and '100', 'unbearable pain'. The change of pain will be reported by comparing the mean VAS before treatment, after 1 week, after 2 week, and 1 week follow-up.
Change from baseline to 2 weeks
Secondary Outcomes (1)
Analgesic drug consumption
Change from baseline to 2 weeks
Study Arms (2)
Acupuncture & NCPB
EXPERIMENTALThe NCPB will be administered once at the start of the trial and the acupuncture will be performed 3 times per week for 2 weeks (6 times in total).
NCPB
ACTIVE COMPARATORThe NCPB alone will be applied to the patients in this group, once at the start of the trial.
Interventions
Acupuncture is applied three times a week for 20 minutes for 2 weeks (total 6 sessions). 9 Acupuncture points, CV12, CV13, P6, SP4, ST36(bilateral),LI4 (bilateral), LR3 (bilateral), ST34 (bilateral), and GB21(bilateral) are used, and CV12, CV13, ST36, and LR3 are electro-stimulated.
An anaesthetic test is performed injecting 2ml mepivacaine. After assessing the efficacy and safety of this test, 10 ml of absolute alcohol is injected via each needle.
Eligibility Criteria
You may qualify if:
- Age over 18 years
- Upper abdominal pain VAS ≥ 5
- Unresectable abdominal malignancy, moderate or severe abdominal pain poorly controlled with pharmacotherapy.
- All patients had advanced cancer diagnosed by histological/cytological examination
- Follow-up possible during the clinical trial
- Written informed consent voluntarily
You may not qualify if:
- Patient with uncorrectable coagulopathy
- Patient with allergy to local anesthesics or alcohol..
- Previous NCPB or had implanted epidural or intrathecal analgesic therapy
- Inability to lie prone
- Disease encasing the celiac plexus on computed Tomography scan
- Patients with psychiatric diseases that could have affected the study assessments
- Significant renal or hepatic disease
- Inability to comprehend or express oneself in the Korean language
- Refusal to participate in the trial or to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Daegu Catholic University Medical Center
Daegu, Kyungsangbukdo, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeong-Chul Seo, KMD, Ph.D
Comprehensive and Integrative Medicine Institute
- PRINCIPAL INVESTIGATOR
Min-Ah Gwak, KMD, Ph.D
Daegu Oriental Hospital of Daegu Haany University
- PRINCIPAL INVESTIGATOR
Seong_Hoon Park, KMD
Comprehensive and Integrative Medicine Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of anesthesiolgy
Study Record Dates
First Submitted
July 29, 2013
First Posted
August 1, 2013
Study Start
March 1, 2013
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
December 22, 2021
Record last verified: 2021-12